Saudi 2026: SFDA Drive for Generics & Local APIs

ha aggiunto una foto Health

2026-01-20 06:36:16 -

Amid evolving global supply‑chain pressures and growing demand for affordable medicines, 2026 marks a decisive year for the Saudi Food and Drug Authority (SFDA) as the Kingdom accelerates its policy push toward generics, active pharmaceutical ingredients (APIs), and local manufacturing. For pharmaceutical companies and API suppliers, this presents a strategic window of opportunity, but only if...

0 Commenti 0 condivisioni 28 Views 0 Anteprima